Gyomor- és nyelőcsőrák: vizsgálatok itt: Románia
10 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 13.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of ASP2138 Together With Chemotherapy and Pembrolizumab in Adults With Gastric Cancer
- Where
- Bucharest, Bucharest Sector 1, Cluj-Napoca
- Életkor
- 18 év and over
- People
- 570 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT07673887 · EU 2025-524557-14-00 - 3. fázisTaking peopleA Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
- Where
- Bucharest, Cluj-Napoca, Craiova, Floresti, Iasi, Timisoara
- Életkor
- 18 év and over
- People
- 500 worldwide
- Run by
- Astellas Pharma Global Development, Inc.
See details and how to joinNCT06901531 · EU 2024-519773-19-00 - 2/3. fázisTaking peopleA Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)
- Where
- Cluj-Napoca, Craiova, Floresti, Iasi, Iași
- Életkor
- 18 év and over
- People
- 690 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07221149 · EU 2025-523263-37-00 - 3. fázisTaking peopleA Study of Ifinatamab Deruxtecan in Subjects With Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma (ESCC) (IDeate-Esophageal01)
- Where
- Bucharest, Cluj-Napoca, Comuna Floresti, Craiova, Iași, Suceava
- Életkor
- 18 év and over
- People
- 510 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06644781 · EU 2023-509630-19-00 - No phaseTaking peoplePerioperative Biomarkers in Colorectal and Gastric Cancer Surgery
- Where
- Bucharest
- Életkor
- 18 év and over
- People
- 320
- Run by
- Bucharest Emergency Hospital
See details and how to joinNCT07881133 - 3. fázisTaking peopleTrial of Trastuzumab Deruxtecan (Enhertu®) Plus Chemotherapy Plus or Minus Pembrolizumab versus Chemotherapy Plus Trastuzumab Plus or Minus Pembrolizumab in First-line Metastatic HER2-positive Gastric or GEJ Cancer
- Where
- Bucharest, Cluj-Napoca, Craiova, Iași, Ovidiu, Suceava
- Életkor
- 18 év and over
- People
- 228 worldwide
- Run by
- Daiichi Sankyo Inc.
See details and how to join2024-513122-27-00 - 3. fázisTaking peopleStudy of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer
- Where
- Bucharest, Cluj-Napoca, Craiova, Iași, Ovidiu, Suceava
- Életkor
- 18 év and over
- People
- 726 worldwide
- Run by
- Daiichi Sankyo
See details and how to joinNCT06731478 - 3. fázisTaking peopleA Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
- Where
- Bucharest, Cluj-Napoca, Craiova, Floresti, Oradea, Suceava
- Életkor
- 18 év and over
- People
- 550 worldwide
- Run by
- Shanghai Henlius Biotech
See details and how to joinNCT06532006 · EU 2024-516633-12-00 - No phaseTaking peopleEndoscopic Submucosal Dissection Registry
- Where
- Bucharest
- Életkor
- 18 év to 100 év
- People
- 200
- Run by
- Carol Davila University of Medicine and Pharmacy
See details and how to joinNCT06033976 - No phaseTaking peopleH. Pylori Screen-and-treat Study in a Population of Young Adults
- Where
- Cluj-Napoca
- Életkor
- 30 év to 34 év
- People
- 6800 worldwide
- Run by
- University of Latvia
See details and how to joinNCT06275204